(Reuters) – Britain’s GSK said on Friday it had paused a late-stage trial of its experimental vaccine against the respiratory syncytial virus (RSV) in pregnant women based on recommendations from an independent committee after a safety assessment.
The world’s biggest vaccine maker did not give further details, but said a trial of the RSV vaccine for older adults was still ongoing.
RSV is a cause of pneumonia in toddlers and the elderly.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shailesh Kuber)
